eMedicine Specialties > Pediatrics: General Medicine > Nephrology

Medullary Sponge Kidney

Author: Howard Trachtman, MD, Program Director, Pediatrics Research, Schneider Children's Hospital, Department of Pediatrics, Division of Nephrology, Professor, Albert Einstein College of Medicine
Contributor Information and Disclosures

Updated: Nov 4, 2009

Introduction

Background

Medullary sponge kidney (MSK) is likely the result of an abnormality in renal development, as evidenced by the occasional presence of embryonal tissue in the affected papillae. Recent findings suggest that medullary sponge kidney may result from disruption of the ureteric bud/metanephric-blastema interface that is critical in normal kidney development.1

Medullary sponge kidney is characterized by ectasia and cystic formation in the medullary collecting duct. This characterization contrasts with autosomal recessive polycystic kidney disease and with autosomal dominant polycystic kidney disease, in which cysts predominantly develop along the cortical collecting tubule or the entire nephron, respectively. Medullary cysts give the kidney the gross anatomic appearance of a sponge. In the absence of hematuria, renal calculi, or infection, the disease is an asymptomatic nonprogressive condition.

Unenhanced coronal volume-rendered (VR) CT image ...

Unenhanced coronal volume-rendered (VR) CT image of the kidneys demonstrates 2 small calculi in the mid portion of the right kidney and 2 small calculi in the lower pole of the left kidney (arrowheads). A large low-density lesion in the lower pole of the right kidney and a small low-density lesion in the upper pole of the left kidney (short arrows) were shown to represent benign simple renal cysts on the contrast enhanced CT images. Image courtesy of Dr. Terri J. Vrtiska, Consultant, Department of Radiology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

Unenhanced coronal volume-rendered (VR) CT image ...

Unenhanced coronal volume-rendered (VR) CT image of the kidneys demonstrates 2 small calculi in the mid portion of the right kidney and 2 small calculi in the lower pole of the left kidney (arrowheads). A large low-density lesion in the lower pole of the right kidney and a small low-density lesion in the upper pole of the left kidney (short arrows) were shown to represent benign simple renal cysts on the contrast enhanced CT images. Image courtesy of Dr. Terri J. Vrtiska, Consultant, Department of Radiology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.


CT image of both kidneys demonstrates brushlike d...

CT image of both kidneys demonstrates brushlike densities throughout multiple papillae of both kidneys consistent with renal tubular ectasia. Correlation of the stone disease with the ectatic tubules is diagnostic of medullary sponge kidney. Image courtesy of Dr. Terri J. Vrtiska, Consultant, Department of Radiology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

CT image of both kidneys demonstrates brushlike d...

CT image of both kidneys demonstrates brushlike densities throughout multiple papillae of both kidneys consistent with renal tubular ectasia. Correlation of the stone disease with the ectatic tubules is diagnostic of medullary sponge kidney. Image courtesy of Dr. Terri J. Vrtiska, Consultant, Department of Radiology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.


Pathophysiology

The kidney is the primary organ affected. Ectasia and cystic malformation are present along the intrapyramidal or intrapapillary portion of the medullary collecting duct. Cysts may be heterogeneous in size within one kidney and between the 2 kidneys, ranging in size from 1-3 mm. Cysts may communicate and often contain spherical concretions composed of apatite.

The association of medullary sponge kidney with different malformation conditions suggests that it belongs to the developmental disorders that result from disruption of the ureteric bud-metanephric blastema interface. This is based on the occasional presence of remnant embryonal tissue in the affected papillae. Pathological studies suggest that medullary sponge kidney is due to an obstruction of the fetal-collecting duct or to a structural defect caused by hypercalciuria. Although the cause of medullary sponge kidney is unknown, family occurrence suggests a genetic component. 

Medullary sponge kidney has been linked to defects in tubular function, including acidification and concentration. Two patients with medullary sponge kidney in association with distal renal tubular acidosis, late sensorineural hearing loss, and a mutation in the proton pump genes ATP6V1B1 and ATP6V0A4 were described.2

Medullary sponge kidney may be part of other syndromes and conditions such as Beckwith-Wiedemann syndrome (BWS), hemihypertrophy, Caroli disease, Ehlers-Danlos syndrome, Marfan syndrome, and pyloric stenosis. Medullary sponge kidney may occur in as many as 12.5% of cases of BWS, if congenital hemihypertrophy is part of the clinical picture. Finally, medullary sponge kidney was recently described in a 10-year-old boy with Rabson-Mendenhall syndrome (ie, severe insulin resistance, hyperinsulinemia, postprandial hyperglycemia, growth retardation, and dysmorphic features).3

Frequency

United States

The prevalence rate is 1 case per 5,000-20,000 population. Medullary sponge kidney may be detected in 0.5-1% of asymptomatic individuals who undergo renal imaging studies for assorted clinical indications.

International

Evidence indicates that worldwide incidence of medullary sponge kidney is similar to that found in the United States.

Mortality/Morbidity

Morbidity or mortality is not directly related to medullary sponge kidney. In the absence of hematuria, urinary tract infection (UTI), or renal calculi, medullary sponge kidney is usually a nonprogressive asymptomatic condition. Under normal conditions, patients may have a mild urinary-concentrating defect or low-grade proteinuria.

Patients have a higher risk for developing calcium oxalate/apatite or struvite renal calculi. Factors that may contribute to the susceptibility to recurrent calcium urolithiasis include: (1) urine stasis, (2) incomplete renal tubular acidosis (RTA) with a mild defect in urinary acidification and increased urine pH levels, (3) hypocitric aciduria, and (4) hypercalciuria. Patients are usually aged 20-50 years at presentation, although the condition may occur in children younger than 5 years. As many as 20% of adults with kidney stones may have medullary sponge kidney . The lifetime risk of renal stones may be as high as 60% in adults with medullary sponge kidney. The prevalence of medullary sponge kidney is higher (8.5%) in adults with renal stones compared with the control population (1.5%). The corresponding figure in children is unknown. Among patients with kidney stones, hypercalciuria may occur in 40-50%, and recurrent gross hematuria may occur in 10-20%.

Hyperparathyroidism is frequently associated with medullary sponge kidney and was thought to cause the disease and trigger stone formation. However, the urinary findings and clinical features of medullary sponge kidney usually precede the detection of hyperparathyroidism. 

Although no evidence indicates that risk of UTIs is higher in patients with medullary sponge kidney, as many as 5% of males and 35% of females have a UTI. These patients do not have an increased frequency of concomitant structural anomalies (eg, vesicoureteral reflux) to account for the occurrence of UTI.

Race

No epidemiologic data indicate that incidence varies among racial or ethnic subgroups.

Sex

No evidence indicates that the frequency differs between the sexes. Fewer than 5% of cases are familial, and a clear genetic basis for medullary sponge kidney has not been established. The only genetic pattern observed in select pedigrees is an autosomal dominant type of transmission. Medullary sponge kidney appears to be somewhat more severe in women; the incidence of renal calculi and UTIs in women is higher than in men.

Age

Symptoms occur primarily in adults aged 20-50 years; however, infants as young as 2 years and adolescents have shown clinical symptoms.

Clinical

History

  • Patients with medullary sponge kidney (MSK) are usually asymptomatic.
  • Patients may develop microhematuria or signs and symptoms of gross hematuria, renal stone development, or urinary tract infection (UTI).

Physical

  • Although physical examination findings are usually normal, as many as 25% of patients have hemihypertrophy, and 10% of patients with hemihypertrophy may have medullary sponge kidney, although no explanation for this association is noted. Children with medullary sponge kidney and hemihypertrophy may have an incomplete form of Beckwith-Wiedemann syndrome (BWS). Moreover, because of the high risk of malignancies in patients with BWS, these patients should be periodically screened for malignancies, including abdominal tumors.
  • Urinalysis findings may show hematuria, low-grade proteinuria, and mild acidification and concentrating defects.

Causes

The cause of medullary sponge kidney is unknown.

  • No cases link medullary sponge kidney to a drug or environmental exposure.
  • Cases occasionally occur in a familial pattern consistent with autosomal dominant transmission. In these circumstances, medullary sponge kidney may be associated with unilateral renal agenesis or other renal or genitourinary tract abnormalities.

More on Medullary Sponge Kidney

Overview: Medullary Sponge Kidney
Differential Diagnoses & Workup: Medullary Sponge Kidney
Treatment & Medication: Medullary Sponge Kidney
Follow-up: Medullary Sponge Kidney
Multimedia: Medullary Sponge Kidney
References

References

  1. Gambaro G, Feltrin GP, Lupo A, et al. Medullary sponge kidney (Lenarduzzi-Cacchi-Ricci disease): a Padua Medical School discovery in the 1930s. Kidney Int. Feb 2006;69(4):663-70. [Medline].

  2. Carboni I, Andreucci E, Caruso MR, et al. Medullary sponge kidney associated with primary distal renal tubular acidosis and mutations of the H+-ATPase genes. Nephrol Dial Transplant. Sep 2009;24(9):2734-8. [Medline].

  3. Harris AM, Hall B, Kriss VM, Fowlkes JL, Kiessling SG. Rabson-Mendenhall syndrome: medullary sponge kidney, a new component. Pediatr Nephrol. Dec 2007;22(12):2141-4. [Medline].

  4. Abeshouse BS, Abeshouse GA. Sponge kidney: a review of the litrature and a report of five cases. J Urol. Aug 1960;84:252-67. [Medline].

  5. Avner ED. Medullary sponge kidney. In: Greenber A, Cheung AK, Coffman TM, et al, eds. NKF Primer on Kidney Disease. 1997.

  6. Osther PJ, Mathiasen H, Hansen AB, et al. Urinary acidification and urinary excretion of calcium and citrate in women with bilateral medullary sponge kidney. Urol Int. 1994;52(3):126-30. [Medline].

  7. Patriquin HB, O'Regan S. Medullary sponge kidney in childhood. AJR Am J Roentgenol. Aug 1985;145(2):315-9. [Medline].

  8. [Guideline] Tiselius HG, Alken P, Buck C, Gallucci M, Knoll T, Sarica K, Turk C. Guidelines on urolithiasis. Arnhem, The Netherlands: European Association of Urology (EAU); 2008 Mar. [Full Text].

Further Reading

Keywords

medullary sponge kidney, MSK, medullary cysts, renal cyst, Beckwith-Wiedemann syndrome, BWS, hemihypertrophy, Caroli disease, Ehlers-Danlos syndrome, Marfan syndrome, Marfan's syndrome, pyloric stenosis, kidney stones, treatment, diagnosis

Contributor Information and Disclosures

Author

Howard Trachtman, MD, Program Director, Pediatrics Research, Schneider Children's Hospital, Department of Pediatrics, Division of Nephrology, Professor, Albert Einstein College of Medicine
Howard Trachtman, MD is a member of the following medical societies: American Society of Hypertension, American Society of Nephrology, American Society of Pediatric Nephrology, and Society for Pediatric Research
Disclosure: Nothing to disclose.

Medical Editor

Uri S Alon, MD, Director of Research and Education, Department of Pediatrics, Division of Pediatric Nephrology, Children's Mercy Hospital of Kansas City; Professor, University of Missouri at Kansas City
Uri S Alon, MD is a member of the following medical societies: American Federation for Medical Research
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from financial planner; Avanir Pharma Stock Investment from financial planner ; WebMD Salary and stock Employment and investment from financial planner

Managing Editor

Frederick J Kaskel, MD, PhD, Director of the Division and Training Program in Pediatric Nephrology, Vice Chair, Department of Pediatrics, Montefiore Medical Center and Albert Einstein School of Medicine
Frederick J Kaskel, MD, PhD is a member of the following medical societies: American Academy of Pediatrics, American Association for the Advancement of Science, American Pediatric Society, American Physiological Society, American Society of Nephrology, American Society of Pediatric Nephrology, American Society of Transplantation, Eastern Society for Pediatric Research, Federation of American Societies for Experimental Biology, International Society of Nephrology, National Kidney Foundation, New York Academy of Sciences, Renal Physicians Association, Sigma Xi, and Society for Pediatric Research
Disclosure: Nothing to disclose.

CME Editor

Daniel Rauch, MD, FAAP, Director, Pediatric Hospitalist Program, Associate Professor, Department of Pediatrics, New York University School of Medicine
Daniel Rauch, MD, FAAP is a member of the following medical societies: Ambulatory Pediatric Association, American Academy of Pediatrics, and Society of Hospital Medicine
Disclosure: Baxter Honoraria Consulting

Chief Editor

Craig B Langman, MD, The Isaac A Abt, MD, Professor of Kidney Diseases, Feinberg School of Medicine, Northwestern University; Division Head of Kidney Diseases, Children's Memorial Hospital, Chicago
Craig B Langman, MD is a member of the following medical societies: American Academy of Pediatrics, American Society of Nephrology, and International Society of Nephrology
Disclosure: Amgen Grant/research funds None; Altus Pharmaceuticals Grant/research funds None; Genzyme Grant/research funds None; Merck Grant/research funds None; NIH Grant/research funds None

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.